Home
>
National Drug Code (NDC)
>
Berinert
Berinert - 63833-825-02 - (HUMAN C1-ESTERASE INHIBITOR)
Drug Information of Berinert
| Product NDC: | 63833-825 |
| Proprietary Name: | Berinert |
| Non Proprietary Name: | HUMAN C1-ESTERASE INHIBITOR |
| Active Ingredient(s): | & nbsp; HUMAN C1-ESTERASE INHIBITOR |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Berinert
| Product NDC: | 63833-825 |
| Labeler Name: | CSL Behring GmbH |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125287 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20111222 |
Package Information of Berinert
| Package NDC: | 63833-825-02 |
| Package Description: | 1 KIT in 1 CARTON (63833-825-02) * 10 mL in 1 VIAL (63833-835-01) * 10 mL in 1 VIAL (63833-765-15) |
NDC Information of Berinert
| NDC Code | 63833-825-02 |
| Proprietary Name | Berinert |
| Package Description | 1 KIT in 1 CARTON (63833-825-02) * 10 mL in 1 VIAL (63833-835-01) * 10 mL in 1 VIAL (63833-765-15) |
| Product NDC | 63833-825 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | HUMAN C1-ESTERASE INHIBITOR |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20111222 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring GmbH |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
